WHEN PAIN IS CHRONIC AND DISABLING: RESEARCHERS CREATE MINUSPAIN, THE FIRST SCIENTIFIC CENTER IN THE COUNTRY TO STUDY THIS ISSUE
With the aim of developing translational neuroscience research on pain and for the formation of advanced human capital in the scientific and clinical area, the Millennium Nucleus MiNuSPain is born, which associates five research groups, whose competencies range from cutting-edge biomedical research to clinical studies whose collaborations are reflected in projects, publications, international conferences and joint thesis supervision.
The center’s axis of action is the determination of the key molecular targets involved in neuropathic pain. In particular, focused on the study of cellular and molecular mechanisms in preclinical and clinical models.
However, the creation of the center was not an easy task. This is what Margarita Calvo, director of the Millennium Nucleus MiNuSPain, confesses. Multiple applications were needed so that in the third, finally, the funds could be awarded to create this project.
The focus on pain was born from the career that all the specialists at the center have developed, conducting various research and academic papers both in Chile and abroad.
“This millennium initiative brings together different researchers working on the same topic, but who have different experiences, and who can collaborate with each other to create synergy. The idea is that, between all of us, make the best of what each one has. So, working together to be able to do a transnational work, more aimed at what is affecting patients today, ”says Calvo.
The director of the center has had an outstanding career in pain research, completing a master’s degree in pain management, a master’s degree in diseases of the peripheral nervous system in Milan to finally do a post-doctorate at the IMI EuroPain Consortium at Oxford University / King’s College London.